Critical appraisal of paroxetine for the treatment of vasomotor symptoms
about
Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis.Comparison of the effects of stellate ganglion block and paroxetine on hot flashes and sleep disturbance in breast cancer survivors
P2860
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@ast
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@en
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@nl
type
label
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@ast
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@en
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@nl
prefLabel
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@ast
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@en
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@nl
P2093
P2860
P356
P1476
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
@en
P2093
Dana Carroll
Katelin Lisenby
Tracy Carter
P2860
P304
P356
10.2147/IJWH.S50804
P407
P577
2015-06-18T00:00:00Z